Jürgen Steffgen Selected Research

Jürgen Steffgen Research Topics

2	Autoimmune Diseases (Autoimmune Disease) 12/2018 - 02/2018
1	Infections 11/2023
1	Lupus Nephritis 11/2023
1	Thrombosis (Thrombus) 11/2020
1	Rheumatoid Arthritis 01/2019
1	Bone Resorption 01/2019
1	Exanthema (Rash) 02/2018
1	Fibrosis (Cirrhosis) 10/2013
1	Chronic Hepatitis C 10/2013
1	Liver Diseases (Liver Disease) 07/2012
1	Crohn Disease (Crohn's Disease) 03/2006
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 03/2006
1	Septic Shock (Toxic Shock Syndrome) 01/2002
1	Respiratory Insufficiency (Respiratory Failure) 01/2002
1	Tuberculosis (Tuberculoses) 01/2002

4	BI 655064IBA 11/2023 - 02/2018
2	Monoclonal AntibodiesIBA 11/2023 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2019
2	deleobuvirIBA 10/2013 - 07/2012
1	GlucocorticoidsIBA 11/2023
1	CD40 Ligand (CD40L)IBA 11/2020
1	AntibodiesIBA 11/2020
1	Matrix Metalloproteinase 3 (Stromelysin 1)IBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	AutoantibodiesIBA 01/2019
1	Immunoglobulin A (IgA)IBA 01/2019
1	Immunoglobulin M (IgM)IBA 01/2019
1	Immunoglobulins (Immunoglobulin)IBA 01/2019
1	LigandsIBA 01/2019
1	Methotrexate (Mexate)FDA LinkGeneric 01/2019
1	Rheumatoid FactorIBA 01/2019
1	Antiviral Agents (Antivirals)IBA 10/2013
1	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 10/2013
1	RNA (Ribonucleic Acid)IBA 10/2013
1	Ribavirin (Virazole)FDA LinkGeneric 07/2012
1	N 30IBA 07/2012
1	p38 Mitogen-Activated Protein KinasesIBA 03/2006
1	doramapimodIBA 03/2006
1	C-Reactive ProteinIBA 03/2006
1	CytokinesIBA 03/2006
1	Isoniazid (Ftivazide)FDA LinkGeneric 01/2002

1	Oral Administration 10/2013
1	Therapeutics 01/2002